These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34526525)

  • 1. K
    Glaser F; Hundehege P; Bulk E; Todesca LM; Schimmelpfennig S; Nass E; Budde T; Meuth SG; Schwab A
    Sci Rep; 2021 Sep; 11(1):18330. PubMed ID: 34526525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting K
    Todesca LM; Gerke M; Bulk EE; Bachmann M; Rudersdorf A; Antonuzzo L; Pillozzi S; Düfer M; Szabo I; Schwab A
    Cell Death Discov; 2024 Jan; 10(1):2. PubMed ID: 38177097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-Regulation of MiRNA-125a-5p Inhibits Cell Proliferation and Increases EGFR-TKI Induced Apoptosis in Lung Cancer Cells.
    Amri J; Molaee N; Karami H
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3361-3367. PubMed ID: 31759360
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    McMahon NP; Solanki A; Wang LG; Montaño AR; Jones JA; Samkoe KS; Tichauer KM; Gibbs SL
    Theranostics; 2024; 14(7):2816-2834. PubMed ID: 38773974
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting Epidermal Growth Factor Receptor by MiRNA-145 Inhibits Cell Growth and Sensitizes NSCLC Cells to Erlotinib.
    Amri J; Molaee N; Baazm M; Karami H
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2781-2787. PubMed ID: 31554377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-staining of K
    Brömmel K; Maskri S; Bulk E; Pethő Z; Rieke M; Budde T; Koch O; Schwab A; Wünsch B
    ChemMedChem; 2020 Dec; 15(24):2462-2469. PubMed ID: 33043595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic glycoengineering sensitizes drug-resistant pancreatic cancer cells to tyrosine kinase inhibitors erlotinib and gefitinib.
    Mathew MP; Tan E; Saeui CT; Bovonratwet P; Liu L; Bhattacharya R; Yarema KJ
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1223-7. PubMed ID: 25690786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BPTF Drives Gastric Cancer Resistance to EGFR Inhibitor by Epigenetically Regulating the C-MYC/PLCG1/Perk Axis.
    Li F; Yu J; Pan T; Feng H; Li J; Yu B; Fan Z; Sang Q; Chen M; Zang M; Hou J; Wu X; Yu Y; Li YY; Yan C; Zhu Z; Su L; Liu B
    Adv Sci (Weinh); 2023 Dec; 10(34):e2303091. PubMed ID: 37863665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Assembly of Erlotinib-Platinum(II) Complexes for Epidermal Growth Factor Receptor-Targeted Photodynamic Therapy.
    Wang H; Lai Y; Li D; Karges J; Zhang P; Huang H
    J Med Chem; 2024 Jan; 67(2):1336-1346. PubMed ID: 38183413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different EGF-induced receptor dimer conformations for signaling and internalization.
    Haubrich J; Zwier JM; Charrier-Savournin F; Prézeau L; Pin JP
    FASEB J; 2024 Jan; 38(1):e23356. PubMed ID: 38071470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of Small-Molecule Fluorescent Probes for the In Vitro Imaging of Calcium-Activated Potassium Channel K
    Brömmel K; Maskri S; Maisuls I; Konken CP; Rieke M; Pethő Z; Strassert CA; Koch O; Schwab A; Wünsch B
    Angew Chem Int Ed Engl; 2020 May; 59(21):8277-8284. PubMed ID: 32097518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IK Channel-Independent Effects of Clotrimazole and Senicapoc on Cancer Cells Viability and Migration.
    Zuccolini P; Barbieri R; Sbrana F; Picco C; Gavazzo P; Pusch M
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Insights into the Atomistic Mechanisms of Action of Small Molecule Inhibitors Targeting the KCa3.1 Channel Pore.
    Nguyen HM; Singh V; Pressly B; Jenkins DP; Wulff H; Yarov-Yarovoy V
    Mol Pharmacol; 2017 Apr; 91(4):392-402. PubMed ID: 28126850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Blockage of KCa3.1 Channel Inhibited Proliferation, Migration and Promoted Apoptosis of Human Hepatocellular Carcinoma Cells.
    Liu Y; Zhao L; Ma W; Cao X; Chen H; Feng D; Liang J; Yin K; Jiang X
    J Cancer; 2015; 6(7):643-51. PubMed ID: 26078795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Lymphocyte Potassium Channels Kv1.3 and KCa3.1 as Targets for Immunosuppression.
    Lam J; Wulff H
    Drug Dev Res; 2011 Nov; 72(7):573-584. PubMed ID: 22241939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of CD151 overexpression on prognosis and therapy in non-small cell lung cancer patients lacking EGFR mutations.
    Wong AH; Nga ME; Chin CY; Tai YK; Wong HC; Soo R; An O; Yang H; Seet JE; Lim YC; Tam JKC; Tran T
    Cell Prolif; 2024 Jul; ():e13708. PubMed ID: 38982031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supramolecular Probes for Assessing Glutamine Uptake Enable Semi-Quantitative Metabolic Models in Single Cells.
    Xue M; Wei W; Su Y; Johnson D; Heath JR
    J Am Chem Soc; 2016 Mar; 138(9):3085-93. PubMed ID: 26916347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular acidity impedes KCa3.1 activation by Riluzole and SKA-31.
    Cozzolino M; Panyi G
    Front Pharmacol; 2024; 15():1380655. PubMed ID: 38638868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells.
    Mumenthaler SM; Foo J; Choi NC; Heise N; Leder K; Agus DB; Pao W; Michor F; Mallick P
    Cancer Inform; 2015; 14(Suppl 4):19-31. PubMed ID: 26244007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: The HDAC inhibitor, MPT0E028, enhances erlotinib induced cell death in EGFR-TKI-resistant NSCLC cells.
    Chen M-; Chen C-; Wang J-; Tsai A-; Liou J-; Pan S-; Teng C-
    Cell Death Dis; 2024 Jul; 15(7):490. PubMed ID: 38982073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.